These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 7992922)

  • 1. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.
    Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M
    Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.
    Correa-Sales C; Rabin BC; Maze M
    Anesthesiology; 1992 Jun; 76(6):948-52. PubMed ID: 1350889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifedipine, an L-type calcium channel blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine.
    Reid K; Guo TZ; Davies MF; Maze M
    J Pharmacol Exp Ther; 1997 Dec; 283(3):993-9. PubMed ID: 9399968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis toxin-mediated ribosylation of G proteins blocks the hypnotic response to an alpha 2-agonist in the locus coeruleus of the rat.
    Correa-Sales C; Reid K; Maze M
    Pharmacol Biochem Behav; 1992 Nov; 43(3):723-7. PubMed ID: 1360160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
    Rabin BC; Guo TZ; Gregg K; Maze M
    Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists.
    Vulliemoz Y; Whittington RA; Virag L
    Brain Res; 1999 Dec; 849(1-2):169-74. PubMed ID: 10592299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.
    Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M
    J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats.
    Horvàth G; Szikszay M; Benedek G
    Anesth Analg; 1992 Jun; 74(6):884-8. PubMed ID: 1375817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats.
    Hayashi Y; Guo TZ; Maze M
    Anesth Analg; 1996 Sep; 83(3):606-10. PubMed ID: 8780290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin and 4-aminopyridine differentially affect the hypnotic-anesthetic action of dexmedetomidine and pentobarbital.
    Doze VA; Chen BX; Tinklenberg JA; Segal IS; Maze M
    Anesthesiology; 1990 Aug; 73(2):304-7. PubMed ID: 1974396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat.
    Correa-Sales C; Nacif-Coelho C; Reid K; Maze M
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1046-9. PubMed ID: 1361568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
    Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
    Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine.
    Reid K; Hayashi Y; Guo TZ; Correa-Sales C; Nacif-Coelho C; Maze M
    Pharmacol Biochem Behav; 1994 Jan; 47(1):171-5. PubMed ID: 7906889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
    Doze V; Chen BX; Li Z; Maze M
    Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of alpha 2-adrenergic agonists in the rat.
    Hayashi Y; Rabin BC; Guo TZ; Maze M
    Anesthesiology; 1995 Oct; 83(4):816-22. PubMed ID: 7574062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs acting at calcium channels can influence the hypnotic-anesthetic effect of dexmedetomidine.
    Horváth G; Kovács M; Szikszay M; Benedek G
    Acta Biochim Biophys Hung; 1991-1992; 26(1-4):75-81. PubMed ID: 1688240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic desipramine treatment desensitizes the rat to anesthetic and antinociceptive effects of the alpha2-adrenergic agonist dexmedetomidine.
    Guo TZ; Reid K; Davies MF; Nacif-Coelho C; Rabin BC; Gonzalez F; Maze M
    Anesthesiology; 1998 Jun; 88(6):1634-42. PubMed ID: 9637658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine injection into the locus ceruleus produces antinociception.
    Guo TZ; Jiang JY; Buttermann AE; Maze M
    Anesthesiology; 1996 Apr; 84(4):873-81. PubMed ID: 8638842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors.
    Doze VA; Chen BX; Maze M
    Anesthesiology; 1989 Jul; 71(1):75-9. PubMed ID: 2568769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.